Consolidated Statements of Cash Flows - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022
Operating activities:
Net income	$ 108,280	$ 25,757	$ 7,796
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation, amortization, and accretion	35,721	34,329	32,819
Impairments and other charges	109	2,966	2,804
Gain on investments	(8,604)	(539)	(180)
Provision (benefit) for deferred income taxes	(94,455)	(734)	537
Equity-based compensation expense	6,572	10,622	6,880
Provision for credit losses	217	285	42
Loss on debt extinguishment	5,535	0	0
Amortization and expense of financing costs	1,389	3,433	3,376
Insurance recoveries associated with damaged equipment	0	(2,850)	(3,750)
Gain on sale of assets	(338)	(562)	(1,170)
Other non-cash credits	(1,076)	(1,231)	(482)
Changes in operating assets and liabilities, net of assets acquired:
Accounts receivable	5,702	20,165	(39,848)
Inventories	(8,784)	(23,205)	(4,471)
Prepaid expenses and other current assets	(6,574)	2,176	(4,546)
Trade accounts payable and accrued expenses	(4,140)	(128)	22,705
Other	(3,034)	(278)	(3,555)
Net cash provided by operating activities	36,520	70,206	18,957
Investing activities:
Purchases of property, plant, and equipment, net	(60,680)	(38,152)	(40,056)
Acquisition of businesses, net	0	0	(917)
Purchases of investments	(1,021)	(350)	0
Proceeds from sale of investments	0	3,900	0
Proceeds from sale of property, plant, and equipment	2,917	6,661	1,706
Proceeds from insurance recoveries associated with damaged equipment	0	2,850	3,750
Other investing activities	(275)	(1,936)	(987)
Net cash used in investing activities	(59,059)	(27,027)	(36,504)
Financing activities:
Proceeds from credit agreements and long-term debt	184,820	97,529	13,825
Principal payments on credit agreements and long-term debt	(163,579)	(100,497)	(12,483)
Payments on finance lease obligations	(1,438)	(1,695)	(1,302)
Debt issuance costs	(6,648)	0	0
Shares withheld for taxes on equity-based compensation	(3,006)	0	0
Other financing activities	(1,280)	0	0
Net cash provided by (used in) financing activities	8,869	(4,663)	40
Effect of exchange rate changes on cash	(1,607)	377	(452)
Increase (decrease) in cash and cash equivalents	(15,277)	38,893	(17,959)
Cash and cash equivalents at beginning of period	52,485	13,592	31,551
Cash, cash equivalents, and restricted cash at end of period	37,208	52,485	13,592
Reconciliation of cash, cash equivalents, and restricted cash to the consolidated balance sheets
Cash and cash equivalents at end of period	36,987	52,485	13,592
Restricted cash at end of period	221	0	0
Total cash, cash equivalents, and restricted cash at end of period shown in the consolidated statements of cash flows	$ 37,208	$ 52,485	$ 13,592